BRAIDWELL LP - Q1 2024 holdings

$3.1 Billion is the total value of BRAIDWELL LP's 70 reported holdings in Q1 2024. The portfolio turnover from Q4 2023 to Q1 2024 was 50.0% .

 Value Shares↓ Weighting
 GUARDANT HEALTH INCnote11/1$183,591,669
-2.9%
268,252,0000.0%5.92%
-14.8%
BuyBRIDGEBIO PHARMA INCnote 2.500% 3/1$146,211,682
+5.6%
135,838,000
+18.8%
4.71%
-7.3%
BuyEXACT SCIENCES CORPnote 0.375% 3/0$133,113,600
+8.1%
144,000,000
+9.9%
4.29%
-5.2%
 NOVOCURE LTDnote11/0$124,627,695
+5.7%
135,834,0000.0%4.02%
-7.3%
BuyAPOGEE THERAPEUTICS INC$122,435,122
+543.4%
1,842,515
+170.5%
3.95%
+464.5%
BuyNUVASIVE INCnote 0.375% 3/1$109,038,179
+46.8%
114,206,000
+41.8%
3.51%
+28.8%
NBIX BuyNEUROCRINE BIOSCIENCES INC$100,710,425
+6.9%
730,209
+2.1%
3.25%
-6.2%
ARGX BuyARGENX SEsponsored adr$86,549,105
+48.5%
219,824
+43.5%
2.79%
+30.3%
PCVX SellVAXCYTE INC$82,839,742
+2.3%
1,212,703
-6.0%
2.67%
-10.3%
BuyNEOGENOMICS INCnote 0.250% 1/1$82,605,050
+64.6%
103,580,000
+57.9%
2.66%
+44.4%
BuyDEXCOM INCnote 0.250%11/1$71,589,769
+51.7%
65,000,000
+44.4%
2.31%
+33.0%
LEGN BuyLEGEND BIOTECH CORPsponsored ads$69,764,462
+106.1%
1,243,795
+121.1%
2.25%
+80.9%
BuyINSMED INCnote 1.750% 1/1$69,429,090
+23.7%
64,887,000
+23.9%
2.24%
+8.6%
BuyINSULET CORPnote 0.375% 9/0$68,854,500
-5.3%
66,000,000
+4.8%
2.22%
-16.9%
PEN BuyPENUMBRA INC$66,037,177
+17.8%
295,892
+32.8%
2.13%
+3.4%
MRVI BuyMARAVAI LIFESCIENCES HLDGS I$62,614,393
+89.6%
7,221,960
+43.3%
2.02%
+66.4%
 SAREPTA THERAPEUTICS INCnote 1.250% 9/1$59,309,620
+15.1%
50,666,0000.0%1.91%
+1.1%
VKTX NewVIKING THERAPEUTICS INC$58,474,200713,100
+100.0%
1.88%
XENE SellXENON PHARMACEUTICALS INC$56,309,874
-25.8%
1,308,011
-20.6%
1.82%
-34.9%
IRTC SellIRHYTHM TECHNOLOGIES INC$56,057,812
-7.8%
483,257
-14.9%
1.81%
-19.1%
ALGN BuyALIGN TECHNOLOGY INC$55,501,116
+38.4%
169,252
+15.7%
1.79%
+21.5%
 BRIDGEBIO PHARMA INCnote 2.250% 2/0$55,137,279
-3.8%
67,294,0000.0%1.78%
-15.6%
BuyIRONWOOD PHARMACEUTICALS INCnote 1.500% 6/1$53,701,147
+218.3%
52,740,000
+240.3%
1.73%
+179.2%
GH BuyGUARDANT HEALTH INC$51,096,467
+148.9%
2,476,804
+226.4%
1.65%
+118.4%
 TRAVERE THERAPEUTICS INCnote 2.500% 9/1$49,645,727
+4.1%
56,031,0000.0%1.60%
-8.7%
NewCG ONCOLOGY INC$49,617,3171,130,235
+100.0%
1.60%
KROS SellKEROS THERAPEUTICS INC$48,814,490
+9.7%
737,379
-34.1%
1.57%
-3.7%
TMDX BuyTRANSMEDICS GROUP INC$45,438,422
+389.1%
614,531
+422.1%
1.46%
+329.3%
AVDL NewAVADEL PHARMACEUTICALS PLCsponsored adr$45,071,7932,668,549
+100.0%
1.45%
GKOS BuyGLAUKOS CORP$42,494,240
+120.2%
450,676
+85.6%
1.37%
+93.2%
BuyPARAGON 28 INC$41,565,271
-0.5%
3,365,609
+0.1%
1.34%
-12.7%
ISRG NewINTUITIVE SURGICAL INC$40,108,545100,500
+100.0%
1.29%
DAWN SellDAY ONE BIOPHARMACEUTICALS I$35,909,590
-41.7%
2,173,704
-48.4%
1.16%
-48.8%
 KARYOPHARM THERAPEUTICS INCnote 3.000%10/1$35,793,199
+8.5%
65,976,0000.0%1.15%
-4.8%
BuyALPHATEC HLDGS INCnote 0.750% 8/0$33,852,988
+19.3%
32,434,000
+21.2%
1.09%
+4.7%
FDMT New4D MOLECULAR THERAPEUTICS IN$33,532,1721,052,485
+100.0%
1.08%
KIDS  ORTHOPEDIATRICS CORP$32,302,573
-10.3%
1,107,7700.0%1.04%
-21.3%
KRYS SellKRYSTAL BIOTECH INC$31,509,446
+29.5%
177,089
-9.7%
1.02%
+13.6%
RLAY NewRELAY THERAPEUTICS INC$31,075,1923,743,999
+100.0%
1.00%
IRWD NewIRONWOOD PHARMACEUTICALS INC$30,396,5333,489,843
+100.0%
0.98%
KNSA NewKINIKSA PHARMACEUTICALS LTD$27,478,2871,392,716
+100.0%
0.89%
TMO SellTHERMO FISHER SCIENTIFIC INC$27,403,470
-31.8%
47,149
-37.8%
0.88%
-40.2%
RGEN BuyREPLIGEN CORP$26,270,397
+42.3%
142,836
+39.1%
0.85%
+24.9%
NVRO  NEVRO CORP$25,650,754
-32.9%
1,776,3680.0%0.83%
-41.1%
INSP SellINSPIRE MED SYS INC$21,799,467
-42.0%
101,492
-45.0%
0.70%
-49.1%
CGEM  CULLINAN ONCOLOGY INC$21,144,340
+67.2%
1,240,8650.0%0.68%
+46.8%
 TOURMALINE BIO INC$20,766,178
-12.5%
906,8200.0%0.67%
-23.3%
NewLEXEO THERAPEUTICS INC$20,733,3031,322,277
+100.0%
0.67%
SellIRONWOOD PHARMACEUTICALS INCnote 0.750% 6/1$19,937,500
-49.5%
20,000,000
-46.7%
0.64%
-55.7%
NewHAEMONETICS CORP MASSnote3/0$19,846,65021,500,000
+100.0%
0.64%
 SPYRE THERAPEUTICS INC$19,533,950
+76.3%
515,0000.0%0.63%
+54.8%
BMRN NewBIOMARIN PHARMACEUTICAL INC$19,118,377218,896
+100.0%
0.62%
BuySTRUCTURE THERAPEUTICS INCsponsored ads$18,679,374
+63.6%
435,823
+55.6%
0.60%
+43.7%
BCRX SellBIOCRYST PHARMACEUTICALS INC$17,168,251
-49.9%
3,379,577
-40.9%
0.55%
-56.0%
ITOS NewITEOS THERAPEUTICS INC$15,854,7811,162,374
+100.0%
0.51%
SellMINERALYS THERAPEUTICS INC$14,809,758
-14.9%
1,147,154
-43.3%
0.48%
-25.4%
ALEC SellALECTOR INC$14,331,838
-46.0%
2,380,704
-28.4%
0.46%
-52.6%
ARQT NewARCUTIS BIOTHERAPEUTICS INC$12,883,0001,300,000
+100.0%
0.42%
ELEV NewELEVATION ONCOLOGY INC$12,197,3292,377,647
+100.0%
0.39%
BBIO NewBRIDGEBIO PHARMA INC$10,662,051344,827
+100.0%
0.34%
IOVA NewIOVANCE BIOTHERAPEUTICS INC$9,781,526660,022
+100.0%
0.32%
DCPH SellDECIPHERA PHARMACEUTICALS IN$9,589,684
-49.2%
609,643
-47.9%
0.31%
-55.4%
OLMA NewOLEMA PHARMACEUTICALS INC$7,973,174704,344
+100.0%
0.26%
LUNG SellPULMONX CORP$6,976,055
-30.6%
752,541
-4.5%
0.22%
-39.0%
 CUTERA INCnote 4.000% 6/0$6,435,138
-1.7%
29,000,0000.0%0.21%
-13.8%
DBVT  DBV TECHNOLOGIES S Asponsored adr$5,927,170
-20.7%
7,843,2850.0%0.19%
-30.3%
SellCUTERA INCnote 2.250% 6/0$5,742,132
-31.4%
25,240,000
-20.9%
0.18%
-39.9%
OM  OUTSET MED INC$5,328,948
-59.0%
2,400,4270.0%0.17%
-63.9%
ADPT  ADAPTIVE BIOTECHNOLOGIES COR$4,357,543
-34.5%
1,357,4900.0%0.14%
-42.6%
HROW SellHARROW INC$1,666,543
-90.1%
125,967
-91.6%
0.05%
-91.2%
CMPX ExitCOMPASS THERAPEUTICS INC$0-317,761
-100.0%
-0.02%
ExitNANOSTRING TECHNOLOGIES INCnote 2.625% 3/0$0-3,650,000
-100.0%
-0.10%
ExitHILLEVAX INC$0-203,407
-100.0%
-0.12%
ExitIONIS PHARMACEUTICALS INCnote 4/0$0-5,240,000
-100.0%
-0.20%
VRDN ExitVIRIDIAN THERAPEUTICS INC$0-323,102
-100.0%
-0.26%
ExitNEOGENOMICS INCnote 1.250% 5/0$0-10,000,000
-100.0%
-0.34%
RAPT ExitRAPT THERAPEUTICS INC$0-389,300
-100.0%
-0.36%
DNLI ExitDENALI THERAPEUTICS INC$0-461,769
-100.0%
-0.36%
DYN ExitDYNE THERAPEUTICS INC$0-755,811
-100.0%
-0.37%
MRUS ExitMERUS N V$0-370,679
-100.0%
-0.37%
ExitTRAVERE THERAPEUTICS INCnote 2.250% 3/0$0-16,850,000
-100.0%
-0.41%
ExitTHIRD HARMONIC BIO INC$0-1,316,018
-100.0%
-0.53%
ExitINVITAE CORPnote 2.000% 9/0$0-16,781,000
-100.0%
-0.54%
TERN ExitTERNS PHARMACEUTICALS INC$0-2,318,050
-100.0%
-0.55%
AMGN ExitAMGEN INC$0-58,200
-100.0%
-0.62%
LNTH ExitLANTHEUS HLDGS INC$0-495,100
-100.0%
-1.13%
IMCR ExitIMMUNOCORE HLDGS PLCads$0-611,365
-100.0%
-1.53%
ExitTANDEM DIABETES CARE INCnote 1.500% 5/0$0-71,051,000
-100.0%
-2.47%
ExitASCENDIS PHARMA A/Snote 2.250% 4/0$0-126,897,000
-100.0%
-4.79%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2024-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
GUARDANT HEALTH INC7Q2 20246.9%
NOVOCURE LTD7Q2 20244.3%
BRIDGEBIO PHARMA INC7Q2 20245.1%
XENON PHARMACEUTICALS INC7Q2 20243.1%
VAXCYTE INC7Q2 20243.0%
NUVASIVE INC7Q2 20243.5%
ALPHATEC HLDGS INC7Q2 20243.6%
GLAUKOS CORP7Q2 20243.0%
ALIGN TECHNOLOGY INC7Q2 20242.6%
IRHYTHM TECHNOLOGIES INC7Q2 20242.2%

View BRAIDWELL LP's complete holdings history.

Latest filings
TypeFiled
N-PX2024-08-30
13F-HR2024-08-14
13F-HR2024-05-15
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15

View BRAIDWELL LP's complete filings history.

Export BRAIDWELL LP's holdings